Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 250Carcinoma, Non-Small-Cell Lung 86Carcinoma, Renal Cell 62Neoplasm Metastasis 53Neoplasms 51Prostatic Neoplasms 35Lung Neoplasms 32Uveal Melanoma 29Pancreatic Neoplasms 28Carcinoma, Hepatocellular 25Brain Neoplasms 24Colorectal Neoplasms 23Sarcoma 22Breast Neoplasms 20Squamous Cell Carcinoma of Head and Neck 18Small Cell Lung Carcinoma 18Kidney Neoplasms 18Skin Neoplasms 17Diabetes Mellitus, Insulin-Dependent, 12 17Carcinoma, Transitional Cell 17Ovarian Neoplasms 15Urinary Bladder Neoplasms 14Triple Negative Breast Neoplasms 14Mesothelioma 13Glioblastoma 13Uterine Cervical Neoplasms 12Recurrence 12Multiple Myeloma 11Lymphoma 11Clear-cell metastatic renal cell carcinoma 11

Interventions

Radiotherapy 38Radiotherapy, Intensity-Modulated 12Cisplatin 12Amifostine 11Paclitaxel 7Carboplatin 7Radiosurgery 6Etoposide 5Brachytherapy 5Surgical Procedures, Operative 4Low-Level Light Therapy 4Donepezil 4Chemotherapy, Adjuvant 4Bevacizumab 4sargramostim 3Surveys and Questionnaires 3Radiation 3Proton Therapy 3Neuropsychological Tests 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Heavy Ion Radiotherapy 3Filgrastim 3Diet Therapy 3Chemoradiotherapy 3Blood Specimen Collection 3Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Patient Reported Outcome Measures 2Lithium 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Injuries × Ipilimumab × Clear all
NCT02406183 2017-01-10

Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma

University Hospital, Ghent

Phase 1 Completed
13 enrolled
Dermatologic

Melanoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡